The finding also could explain the observation that people who take GLP-1 agonists tend to reduce their consumption of alcohol.
Although the absolute risk was small, awareness of this potential effect may support informed, patient centred treatment decisions, the study reads
Awareness about the Ozempic stomach paralysis lawsuit helps the public stay informed and cautious regarding medication use
2,3 However, matched stage-for-stage, acral melanoma confers the same risk to the patient in terms of recurrence and regional and distant spread, as other cutaneous melanomas
Cigna's prior authorization for GLP-1 weight loss medications typically requires documentation that the patient has a BMI of 30 or greater (or 27 or greater with qualifying comorbidity), has completed at least three months of a structured lifestyle modification program, and has not responded adequately to lifestyle changes alone